financetom
Business
financetom
/
Business
/
Elevai Labs, Yuva Biosciences File 2 Hair Treatment Patents
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Elevai Labs, Yuva Biosciences File 2 Hair Treatment Patents
Aug 29, 2024 9:20 AM

08:03 AM EDT, 08/28/2024 (MT Newswires) -- Elevai Labs ( ELAB ) said Wednesday it has filed two hair and scalp vitality patents in collaboration with Yuva Biosciences.

The first patent is for a skin, scalp, and hair improvement treatment while the second patent covers the use of exosomes as a delivery system, the company said.

Price: 0.3101, Change: -0.01, Percent Change: -4.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--TPG Said in Advanced Talks to Acquire Pike, Bloomberg Reports
--TPG Said in Advanced Talks to Acquire Pike, Bloomberg Reports
Nov 10, 2025
12:35 PM EST, 11/10/2025 (MT Newswires) -- Price: 55.72, Change: +0.59, Percent Change: +1.07 ...
StandardAero Expands Winnipeg Facility to Boost CF34 Engine Capacity
StandardAero Expands Winnipeg Facility to Boost CF34 Engine Capacity
Nov 10, 2025
12:33 PM EST, 11/10/2025 (MT Newswires) -- StandardAero ( SARO ) has broken ground on a 70,000-square-foot expansion of its maintenance, repair, and overhaul facility for turbofan engines in Winnipeg. The expansion will increase capacity for the CF34-3/8 engine, which powers some of the industry's most popular regional airliners, the company said Monday in a statement. Price: 27.19, Change: +0.35,...
Generic Version of Pfizer's Premarin to Treat Menopausal Symptoms Receives FDA Approval
Generic Version of Pfizer's Premarin to Treat Menopausal Symptoms Receives FDA Approval
Nov 10, 2025
12:33 PM EST, 11/10/2025 (MT Newswires) -- A generic version of Pfizer's ( PFE ) Premarin hormone replacement therapy received US Food and Drug Administration approval for treating menopausal symptoms, the US Department of Health and Human Services said Monday. The generic product is expected to improve affordability and access while ensuring the same safety and efficacy as the brand-name...
Crown Reserve Acquisition Corp. I Announces the Closing of $172,500,000 Initial Public Offering
Crown Reserve Acquisition Corp. I Announces the Closing of $172,500,000 Initial Public Offering
Nov 10, 2025
Grand Cayman, Cayman Islands, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Crown Reserve Acquisition Corp. I (the “Company”) (Nasdaq: CRACU) announced today the closing of its initial public offering of 17,250,000 units at a price of $10.00 per unit, including 2,250,000 units sold pursuant to the full exercise of the underwriter’s over-allotment option. The offering resulted in gross proceeds of $172,500,000....
Copyright 2023-2026 - www.financetom.com All Rights Reserved